Chesnara Plc: Fourth acquisition in two years
12 November 2026
Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor interest with its robust dividend yield and diversified pharmaceutical portfolio. With..
For investors keen on the healthcare sector, McKesson Corporation (NYSE: MCK) stands out as a titan in medical distribution with substantial market influence. With a market..
UnitedHealth Group Incorporated (NYSE: UNH), a prominent player in the healthcare sector, stands out with its robust market capitalization of $265.66 billion. As a leader in..
Investors seeking opportunities within the healthcare sector might find The Cigna Group (NYSE: CI) an intriguing prospect. With a substantial market capitalization of $77.42 billion, Cigna..
As a titan in the healthcare sector, AstraZeneca PLC (NASDAQ: AZN) commands a significant presence with a market capitalization of $323.16 billion. Known for its robust..
For investors keen on exploring the healthcare sector, Novartis AG (NYSE: NVS) presents a compelling opportunity. As a Swiss-based global pharmaceutical giant, Novartis operates within a..
AbbVie Inc. (NYSE: ABBV), a heavyweight in the healthcare sector, continues to capture investor attention with its robust pipeline of pharmaceutical products and potential for growth...
Rapport Therapeutics, Inc. (RAPP), a pivotal player in the biotechnology sector, has recently caught the eye of investors with its impressive potential upside of 73.63%. As..
For investors seeking opportunities in the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents an intriguing proposition. With a market capitalization of $472.35 million, this Latham, New..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is making waves in the biotechnology sector, catching the eye of investors with its promising pipeline of monoclonal antibody therapeutics and..
Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, has been making waves in the healthcare sector, particularly in the biotechnology industry, with a staggering revenue growth..
Emergent BioSolutions Inc. (NYSE: EBS) stands at a compelling junction for investors, offering a potential upside of 21.62% with an average target price of $13.50, as..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is a compelling player in the biotechnology sector, with a focus on developing transformative immunology-based therapies. Headquartered in Waltham, Massachusetts, Zenas..
When it comes to the dynamic world of biotechnology, few companies spark as much interest as REGENXBIO Inc. (NASDAQ: RGNX). With its current market capitalization standing..
Definitive Healthcare Corp. (NASDAQ: DH) is capturing the attention of investors with a striking 152.23% potential upside, as indicated by the average analyst target price. This..
MeiraGTx Holdings plc (NASDAQ: MGTX), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust pipeline of genetic medicine therapies..
Investors eyeing opportunities within the healthcare sector may find Kamada Ltd. (NASDAQ: KMDA) to be a compelling option, particularly with its potential 45.9% upside. Based in..
For investors with a keen eye on the healthcare sector, Auna SA (AUNA), a Luxembourg-based medical care facilities company, presents an intriguing proposition. Despite operating in..
For investors eyeing opportunities in the biotech sector, Bicycle Therapeutics plc (BCYC) offers a compelling story of innovation and potential growth. Headquartered in Cambridge, UK, this..
Arbutus Biopharma Corporation (NASDAQ: ABUS) is an intriguing player in the biotech sector, offering a mix of promise and challenges that could either pave the way..
